Insights from Egyptian ticagrelor study in patients who presented with acute coronary syndrome (ETS in ACS)

Abstract Background Dual antiplatelet therapy with aspirin and a thienopyridine is used to prevent thrombotic complications of acute coronary syndrome (ACS) and percutaneous coronary interventions (PCI). Ticagrelor is an oral, reversible inhibitor of the adenosine diphosphate receptor P2Y12 with a f...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hesham S. Taha, Hossam Kandil, Nabil Farag, Amr Zaki, Hossam Mahrous, Mirna M. Shaker
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2022-06-01
Colecção:	The Egyptian Heart Journal
Assuntos:	Antiplatelet therapy Acute coronary syndrome Cardiovascular death Bleeding
Acesso em linha:	https://doi.org/10.1186/s43044-022-00290-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!